Scinai Immunotherapeutics Ltd. - ADR
News
Scinai Immunotherapeutics (NASDAQ:SCNI) Shares Down 2.6%
Ticker Report Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI - Get Free Report)'s share price fell 2.6% during trading on Wednesday . The company traded as low as $3.36 and last traded at $3.41. 3,701 shares traded...\n more…
IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.
Globe Newswire LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) -- via IBN IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce...\n more…
Scinai Immunotherapeutics regains compliance with Nasdaq listing rule
Seeking Alpha - Healthcare Scinai Immunotherapeutics regains compliance with Nasdaq listing rule...\n more…
Scinai Immunotherapeutics Back on Track with Nasdaq
TipRanks Financial Blog Scinai Immunotherapeutics (SCNI) has released an update. Scinai Immunotherapeutics Ltd. has successfully restructured its finances, converting nearly $29 million of...\n more…
Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000
PR Newswire Scinai Announces Closing of Loan Restructuring Agreement with European Investment Bank Converting Approximately $29 million of Debt to Preferred Equity and Leaving Debt Balance of $273,000 Scinai...\n more…